首页 › 糖尿病 › 阿拉巴马州 › Birmingham
Birmingham AL 糖尿病临床试验
9项针对 糖尿病的研究正在 Birmingham及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
招募中3 期
- Univ of Alabama Birmingham, Birmingham
Advancing Diabetes Management for People With Physical Disabilities Optimally Through Primary Care-Based Telehealth (ADDOPT)
招募中
- UAB Highlands Hospital/Department of Family and Community Medicine, Birmingham
Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities
招募中观察性研究
- Cooper Green Mercy Hospital, Birmingham
NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals
招募中2 期欢迎健康志愿者
- University of Alabama at Birmingham, Birmingham
Empowering Faith-based Communities to Provide Personalized Diabetes Self-management Education and Support (DSMES) in the Magic City
招募中欢迎健康志愿者
- New Hope Baptist Church, Birmingham
CGM for Management of Type 2 Diabetes in Pregnancy
招募中
- University of Alabama at Birmingham, Birmingham
CARBON: UAB Cardiovascular Research Biobank
招募中观察性研究欢迎健康志愿者
- University of Alabama at Birmingham, Birmingham
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
招募中观察性研究
- University of Alabama at Birmingham, Birmingham
Inspire HER: Inspiring the Heart and Emotions for Radical Health
招募中
- University of Alabama at Birmingham, Birmingham
其他城市的 糖尿病试验
- Boston, MA23 项研究
- New York City, NY17 项研究
- Houston, TX16 项研究
- Chicago, IL15 项研究
- Durham, NC14 项研究
- Aurora, CO14 项研究
- Baltimore, MD13 项研究
- Philadelphia, PA12 项研究
- Los Angeles, CA10 项研究
- Washington, DC10 项研究
- San Diego, CA10 项研究
- Indianapolis, IN10 项研究
Birmingham的其他研究
- 癌症（所有类型）30 项研究
- 乳腺癌24 项研究
- 肥胖症23 项研究
- 卵巢癌23 项研究
- 非小细胞肺癌22 项研究
- 急性髓系白血病21 项研究
- 多发性骨髓瘤18 项研究
- 慢性阻塞性肺病17 项研究
- 心血管疾病17 项研究
- 超重16 项研究
- 子宫内膜癌16 项研究
- 2型糖尿病16 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。